Last update :
26/03/2024
Anticancer drug   Crisantaspase  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Erwinase Argentina, Austria, Canada, Denmark, Finland, France, Germany, Great Britain, Greece, Ireland, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Sweden, United States of America
Stability in solutions   Injection   Stability in solutions : Crisantaspase     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 5000 & 10000 UI <25°C Not specified
8 Hour
4480
Manufacturer's stability data

Polypropylen Syringe Sodium chloride 0,9% 5000 & 10000 UI <25°C Not specified
8 Hour
4480
Manufacturer's stability data


  Mentions Légales